Controversies in Antiphospholipid Syndrome: DOACs vs. Warfarin

Controversies in Antiphospholipid Syndrome: DOACs vs. Warfarin  Check out our extensive video library (see channel for our latest videos) Abstract Antiphospholipid syndrome (APS) represents a complex autoimmune disorder characterized by thrombotic events and pregnancy complications in patients with persistent antiphospholipid antibodies. The traditional anticoagulant

Anesthesia Drug Shortages: Crisis Management in the Operating Room

Anesthesia Drug Shortages: Crisis Management in the Operating Room  Check out our extensive video library (see channel for our latest videos) Abstract Anesthesia drug shortages represent a critical challenge facing modern healthcare systems worldwide. This paper examines the complex factors contributing to these shortages,

Cytokine Engineering: IL-2, IL-15, and Beyond

Cytokine Engineering: IL-2, IL-15, and Beyond  Check out our extensive video library (see channel for our latest videos) Abstract This paper looks into cytokine engineering, with particular focus on interleukin-2 (IL-2) and interleukin-15 (IL-15). These proteins play essential roles in immune system regulation and

Deprescribing Proves Effective: New Evidence Shows Frailty Reversal in Older Adults

Deprescribing Proves Effective New Evidence Shows Frailty Reversal in Older Adults  Check out our extensive video library (see channel for our latest videos) Introduction Deprescribing offers a promising solution to the growing challenge of medication burden in older adults. One-third of people

Crystal-Proven vs Clinically Diagnosed Gout: Does It Really Change Long-Term Outcomes?

Crystal-Proven vs Clinically Diagnosed Gout Does It Really Change Long-Term Outcomes  Check out our extensive video library (see channel for our latest videos) Abstract Purpose: This study examines whether crystal-proven diagnosis of gout through synovial fluid analysis produces different long-term patient outcomes compared to clinical

FDA-Approved ADCs: Breaking New Ground in Breast, Lung, and Gastric Cancer Treatment

FDA-Approved ADCs: Breaking New Ground in Breast, Lung, and Gastric Cancer Treatment  Check out our extensive video library (see channel for our latest videos) Introduction FDA-approved ADCs are revolutionizing cancer treatment landscapes, as the fifth most prevalent malignancy globally, gastric cancer ranks

Controversies in Antiphospholipid Syndrome: DOACs vs. Warfarin